Business Context and Reporting Period
This Form 8-K filing by Zimmer Holdings, Inc. (now Zimmer Biomet Holdings, Inc.) reports on the results of the annual meeting of stockholders held on May 2, 2011. The filing details the outcomes of four specific proposals submitted to shareholders for a vote.
Key Financial Metrics
This filing is a current report regarding corporate governance and shareholder voting. It does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity. The filing text does not provide a clear value for any financial metric.
Material Changes
There are no material financial changes reported in this document. The primary events are the election of directors and the approval of advisory compensation proposals.
Guidance, Outlook, and Management Commentary
Based on the voting results for Proposal 3, the Board of Directors determined that future advisory votes on executive compensation will be held annually. The next advisory vote on the frequency of these votes is scheduled to occur no later than the 2017 annual meeting.
Important Facts for Investors to Verify
- Director Election: All eight nominees for the Board of Directors were elected by a majority of votes cast.
- Executive Compensation: Shareholders approved the advisory vote on executive compensation (Proposal 2) with approximately 63% of votes cast in favor (90,636,677 For vs. 52,474,274 Against).
- Voting Frequency: Shareholders voted to hold future advisory compensation votes annually (Proposal 3), with 127,193,230 votes for a one-year frequency.
- Auditor Ratification: The appointment of PricewaterhouseCoopers LLP as the independent registered public accounting firm for 2011 was ratified with overwhelming support (161,682,711 For vs. 1,354,664 Against).